Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd has announced a proposed issue of 1,139,028 ordinary fully paid securities, with the issue date set for December 10, 2025. This move is part of a placement or other type of issue, which could potentially impact the company’s market positioning and stakeholder interests by increasing its capital base.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 549,495
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$514.1M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.